Clinical Trial Results TV
Dr. Lasala and Dr. Popma Discuss the ARRIVE Registry and Drug-Eluting Stents
Dr. John Lasala and Dr. Jeff Popma present an overview of the ARRIVE registry and the
implications of its findings regarding drug eluting stents (DES) and patient care. The
patients were recruited consecutively to avoid selection bias. Higher risk patients had
more complications, especially death, MI, and stent thrombosis. Although the data is not
randomized, the registry outcomes were not so different between bare metal stents (BMS)
and drug eluting stents (DES). Dr. Popma and Dr. Lasala conclude that there is a need for
randomization with complex lesion subset groups to have a more direct basis for comparison
of event rates between BMS and DES. KEYWORDS: ARRIVE registries; Society for Cardiac
and Angiography Interventions (SCAI);Drug eluting stents; Bare metal stents;
cardiovascular event rates.

[ Download video ]


Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 2 total votes.

These statistics are updated nightly. The last update ran on
06-25-2022 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted